What Is the FDA’s New Normal?
Drug Approval During the COVID-19 Pandemic
and Beyond
It’s not an understatement to say that the coronavirus disease 2019 (COVID-19) pandemic has been—and continues to be—a challenge for the US and the world. It has upended many of our critical structures, including our health system and medical treatments. But for organizations such as the US Food and Drug Administration (FDA) and connected institutions … What Is the FDA’s New Normal?<br><em>Drug Approval During the COVID-19 Pandemic <br>and Beyond</em>